首次出版:最新修訂:March 2009交付方式:特快專遞(2-3天送達(dá))
報(bào)告屬性:共0頁(yè)下載目錄 版權(quán)聲明
定購(gòu)電話:0755-82571522、82571566、400-008-1522
24小時(shí)服務(wù)熱線:138 0270 8576 定制報(bào)告
版本 | 在線版 | 電子版+印刷版 | 在線報(bào)告庫(kù)(超1000份報(bào)告)全庫(kù) |
---|---|---|---|
優(yōu)惠價(jià) | RMB 6800 | RMB 7800 | RMB 9800 |
原價(jià) | RMB 9600 | RMB 9800 | - |
在線報(bào)告庫(kù)有超1000份報(bào)告,
全庫(kù)只需9800元,平均每份報(bào)告僅需9.8元!
聯(lián)系電話: 400 008 0586; 0755-82571568
微信掃碼:
Chapter1
ExecutiveSummary
ExecutiveSummary1-1
Introduction1-1
MarketOverview1-1
ScopeofResearch1-2
SummaryofMajorFindings1-2
MarketGrowthandOpportunities1-2
ExamplesofanIndustryChallenge1-3
ComplexityinHandlingandAdministeringEnteral
NutritioninHomeSettings1-3
ExamplesofMarketDrivers1-3
FavorableReimbursementRegulations1-4
IncreasingHealthcareCostsDriveConsumerstoward
CommunityCare1-4
KeyMarketRestraints1-4
ReductioninHospitalStayduetoAdvancementsinMedicalSciences1-4
PreventiveMedicineDecreasingtheNeedforEN1-5
CompetitiveAnalysis1-5
ExamplesofConclusionandRecommendations1-5
Chapter2
IntroductiontotheEnteralNutritionMarket
Introduction2-1
NutritioninClinicalManagement2-1
RoleofDietinClinicalManagement2-1
DefinitionsofEnteralandTotalParenteralNutrition2-2
EnteralNutrition2-2
TotalParenteralNutrition2-3
DifferencesbetweenEnteralandParenteralNutrition2-3
EnteralNutritioninClinicalManagement2-3
RoutesofAdministrationofTubeFeeds2-3
MethodsofAdministrationofTubeFeeds2-4
EnteralNutrition—AdvantagesandDisadvantages2-4
Advantages2-4
Disadvantages2-5
ClassificationofEnteralFeedFormulae2-5
StandardFormulae2-5
SpecializedFormulae2-6
PolymericFormulae2-6
OligomericFormulae2-6
ModularFormulae2-7
IndustryStructure2-7
DistributionChannels2-7
CommunityCare2-8
Hospitals2-8
PurchasingCriteria2-8
RegulatoryandReimbursementOverview2-9
IndustryAssociations2-9
RegulatoryBodies2-9
TheAmericanSocietyforEnteralandParenteralNutrition2-9
InternationalFormulaCouncil2-9
ReimbursementOrganizations2-9
Medicare2-10
Medicaid2-11
RegulationsintheU.S.2-12
TheOrphanDrugAmendmentAct(ODA),19832-12
TheMedicareandMedicalNutritionTherapy(MNT)ActH.R.1582andS.604,20052-12
CompanyProfiles2-13
AbbottLaboratories2-13
CorporateHeadquarters2-13
CompanyOverview2-13
CompanyHistoryandCurrentActivities2-13
FinancialResults2-14
ActivityinEnteralNutritionMarket2-14
ExamplesofIndustryActivities2-14
B.BraunMelsungenAG2-14
CorporateHeadquarters2-14
CompanyOverview2-15
CompanyHistoryandCurrentActivities2-15
FinancialResults2-15
ActivityintheEnteralNutritionMarket2-15
StandardDiets2-15
Disease-specificDiets2-16
ExamplesofIndustryActivity2-16
NovartisAG2-16
CorporateHeadquarters2-16
CompanyOverview2-16
CompanyHistoryandCurrentActivities2-17
FinancialResults2-17
ActivityintheEnteralNutritionMarket2-17
ExamplesofIndustryActivity2-17
Nestle2-18
CorporateHeadquarters2-18
CompanyOverview2-18
CompanyBackgroundandCurrentActivities2-18
FinancialResults2-19
ActivityintheEnteralNutritionMarket2-19
ExamplesofIndustryActivities2-19
NutriciaNorthAmerica2-19
CorporateHeadquarters2-19
CompanyOverview2-20
CompanyBackgroundandCurrentActivities2-20
FinancialResults2-20
ActivitiesintheEnteralNutritionMarket2-20
ExamplesofIndustryActivities2-21
MarketDynamics2-21
MergersandAcquisitions2-21
RoyalNumicoN.VAcquiredEACNutrition2-21
NovartisMedicalNutritionAcquiredSemperClinicalNutrition2-21
NovartisAcquiredMeadJohnson’sAdultMedicalNutritionBusiness2-22
AlliancesandJointVentures2-22
JointVenture:BioGaiaandNovartis2-22
JointVenture:ZevexInternationalandNutricia2-22
IndustryChallenge2-22
Challenge2-22
ComplexityinHandlingandAdministeringEnteralNutritioninHomeSettings2-23
StrategicRecommendations2-23
StrategiestoOvercomeDifficultiesinAdministeringEnteralNutritioninHomeSettings2-23
FocusonCoreAreasofBusiness2-24
EmphasisonResearchandDevelopment2-24
FocusingonValue-addedServices2-24
Chapter3
StrategicAnalysisoftheU.S.EnteralNutritionMarket
MarketOverview3-1
Introduction3-1
ScopeofResearch3-1
ResearchMethodology3-2
MarketDrivers3-2
FavorableReimbursementRegulations3-3
IncreasingHealthcareCostsDriveConsumerstowardCommunityCare3-3
CostBenefitsandEffectivenessofEnteralNutrition(EN)FavoritsUse
OverTotalParenteralNutrition(TPN)3-4
AdvancementsinEnteralFeedingDevicesAidMarketGrowth3-4
CustomizedFormulaeforSpecificDiseases3-5
IncreasingGeriatricPopulationAugmentsDemandforEnteralNutritionProducts3-5
IncreasingResearchandDevelopmentExpendituretowardsDevelopmentofEnteralNutrition3-5
MarketRestraints3-6
ReductioninHospitalStayduetoAdvancementsinMedicalScience3-7
PreventiveMedicineDecreasingtheNeedforEnteralNutrition3-7
ForecastsandTrends3-7
MarketEngineeringMeasurements3-7
UnitShipmentandRevenueForecasts3-8
PricingTrends3-10
TechnologyTrends3-11
NutritionalIngredients3-12
EnteralTubeDevices3-12
CompetitiveAnalysis3-13
CompetitiveStructure3-13
TypesofCompetitors3-14
DistributionStructure3-14
KeyEnd-UserGroups3-14
CompetitiveFactors3-14
MarketShareAnalysis3-14
Chapter4
HealthcareintheU.S.
Healthcare4-1
U.S.HealthcareSystem4-1
HealthcareOrganizations4-1
HealthcareServices4-1
HealthcareFunding4-2
PrivateHealthcare4-3
GovernmentorCharitableHealthcare4-4
CommunityCare4-4
AgingDemographics4-5
HomeEnteralNutrition(HEN)4-6
TrendsandDevelopments4-6
Chapter5
IngredientsUsedinEnteralNutrition—TrendsandOpportunities
EnteralFeedIngredients5-1
TrendsandOpportunities5-1
Carbohydrates5-2
Fiber5-2
PrebioticsandProbiotics5-2
ProteinsandAminoAcids5-3
BranchedChainAminoAcids(BCAAs)5-3
EssentialAminoAcids5-3
FattyAcids5-4
NucleicAcids5-4
Microencapsulation5-4
Biotechnology5-4
Chapter6
DatabaseofKeyIndustryParticipants
KeyIndustryParticipants6-1
ListofManufacturers6-1
Chapter7
DecisionSupportDatabase
ReferenceTables7-1
NumberofNursingHomeResidents7-1
MalePopulation65andAbove7-2
FemalePopulation65andabove7-4
IncidenceofHIV7-7
MortalityduetoCerebrovascularDiseases7-9
PrevalenceofDiabetes
This research investigates the U.S. Enteral Nutrition Market from 2002 to 2005, with forecasts to 2012. It offers a comprehensive insight to the U.S. enteral nutrition market, its structure and developments related to it. It clearly lists and defines the market drivers and restraints that have had an impact in the U.S. scenario.